From negative factor to a critical role in virus pathogenesis: The changing fortunes of Nef

Journal of General Virology

Volumn 77, Issue 10, 1996, Pages 2379-2392

  Harris, Mark ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; NEF PROTEIN;

BIOCHEMISTRY; CELLULAR DISTRIBUTION; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

LENTIVIRUS;

EID: 0030001569     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-10-2379     Document Type: Review

References (121)

1. Aderem, A. (1992). The MARCKS brothers: a family of protein kinase C substrates. Cell 71, 713-716.
2. Ahmad, N. & Venkatesan, S. (1988). Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241, 1481-1485.
3. Aiken, C. & Trono, D. (1995). Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. Journal of Virology 69, 5048-5056.
4. Aiken, C., Konner, J., Landau, N. R., Lenburg, M. E. & Trono, D. (1994). Nef induces CD4 endocytosis : requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864.
5. Aiken, C. Krause, L. Chen, Y. & Trono, D. (1996). Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature-sensitive for CD4 downregulation. Virology 217, 293-300.
6. Aldrovandi, G. M. & Zack, J. A. (1996). Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-Hu mice. Journal of Virology 70, 1505-1511.
7. Allan, J. S., Coligan, J. E., Lee, T., McLane, M. F., Kanki, P. J., Groopman, J. E. & Essex, M. (1985). A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230, 810-813.
8. Almond, N., Kent, K., Cranage, M., Rud, E., Clarke, B., Stott, E. J. & Beale, J. (1995). Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345, 1342-1344.
9. Anderson, S., Shugars, D. C., Swanstrom, R. & Garcia, J. V. (1993). Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. Journal of Virology 67, 4923-4931.
10. Anderson, S. J., Lenburg, M., Landau, N. R. & Garcia, J. V. (1994a). The cytoplasmic domain of CP4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef. Journal of Virology 68, 3092-3101.
11. Anderson, S. J., Levin, S. D. & Perlmutter, R. M. (1994b). Involvement of the protein tyrosine kinase p56lck in T cell signaling and thymocyte development. Advances in Immunology 56, 151-178.
12. Baba, T. W., Jeong, Y. S., Penninck, D., Bronson, R., Greene, M. F. & Ruprecht, R. M. (1995). Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825.
13. Backer, J. M., Mendola, C. E., Fairhurst, J. L. & Kovesdi, I. (1991). The HIV-1 nef protein does not have guanine nucleotide binding, GTPase, or autophosphorylating activities. AIDS Research and Human Retroviruses 7, 1015-1020.
14. Bandres, J. C. & Ratner, L. (1994). Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NFκB and AP-1 in human T cells in vitro after T-cell receptor stimulation. Journal of Virology 68, 3243-3249.
15. Bandres, J. O., Luria, S. & Ratner, L. (1994). Regulation of human immunodeficiency virus Nef protein by phosphorylation. Virology 201, 157-161.
16. Bandres, J. C., Shaw, A. S. & Ratner, L. (1995). HIV-1 Nef protein downregulation of CD4 surface expression : relevance of the Lck binding domain of CD4. Virology 207, 338-341.
17. Baser, M., Werner, A., Bannert, N., Metzner, K. & Kurth, R. (1995). HIV suppression by interleukin-16. Nature 378, 563-564.
18. Baur, A. S., Sawai, E. T., Dazin, P., Fantl, W. J., Cheng-Mayer, C. & Peterlin, B. M. (1994). HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384.
19. Benichou, S., Bomsel, M., Bodeus, M., Durand, H., Doute, M., Letourneur, F., Camonis, J. & Benarous, R. (1994). Physical interaction of the HIV-1 Nef protein with β-COP, a component of non-clathrincoated vesicles essential for membrane traffic. Journal of Biological Chemistry 269, 30073-30076.
20. Benkirane, M., Corbeau, P., Housset, V. & Devaux, C. (1993). An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. EMBO Journal 12, 4909-4921.
21. Benson, R. E., Sanfridson, A., Ottinger, J. S., Doyle, C. & Cullen, B. R. (1993). Downregulation of cell-surface CD4 expression by simian immunodeficiency virus nef prevents viral superinfection. Journal of Experimental Medicine 177, 1561-1566.
22. Binninger, D., Ennen, J., Bonn, D., Norley, S. G. & Kurth, R. (1991). Mutational analysis of the simian immunodeficiency virus SIVmac nef gene. Journal of Virology 65, 5237-5243.
23. Bodeus, M., Mariecardine, A., Bougeret, C., Ramos-Morales, F. & Benarous, R. (1995). In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase. Journal of General Virology 76, 1337-1344.
24. Brady, H. J. M., Pennington, D. J., Miles, C. G. & Dzierzak, E. A. (1993). CD4 cell surface downregulation in HIV-1 nef transgenic mice is a consequence of intracellular sequestration. EMBO Journal 12, 4923-4932.
25. Cheingsong Popov, R., Panagiotidi, C., Ali, M., Bowcock, S., Watkins, P., Aronstam, A., Wassef, M. & Weber, J. (1990). Antibodies to HIV-1 nef(p27): prevalence, significance, and relationship to seroconversion. AIDS Research and Human Retroviruses 6, 1099-1105.
26. Cheng Mayer, C., Iannello, P., Shaw, K., Luciw, P. A. & Levy, J. A. (1989). Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science 246, 1629-1632.
27. Chowers, M. Y., Spina, C. A., Kwoh, T. J., Fitch, N. J. S., Richman, D. D. & Guatelli, J. C. (1994). Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. Journal of Virology 68, 2906-2914.
28. Chowers, M. Y., Pandori, M. W., Spina, C. A., Richman, D. D. & Guatelli, J. C. (1995). The growth advantage conferred by HIV-1 Nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212, 451-457.
29. Coates, K. & Harris, M. (1995), The human immunodeficiency virus type 1 Nef protein functions as a protein kinase C substrate in vitro. Journal of General Virology 76, 837-844.
30. Collette, Y., Chang, H. L., Cerdan, C., Chambost, H., Algarte, M., Mawas, C., Imbert, J., Burny, A. & Olive, D. (1996a). Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 nef gene-induced expression. Journal of Immunology 156, 360-370.
31. Collette, Y., Dutartre, H., Benziane, A., Ramosmorales, F., Benarous, R., Harris, M. & Olive, D. (1996b). Physical and functional interaction of Nef with Lck: HIV-1 Nef-induced T-cell signaling defects. Journal of Biological Chemistry 271, 6333-6341.
32. Culmann, B., Gomard, E., Kieny, M. P., Guy, B., Dreyfus, F., Saimot, A. G., Sereni, D., Sicard, D. & Levy, J. P. (1991). Six epitopes reacting with human cytotoxic CD8 + T cells in the central region of the HIV-1 NEF protein. Journal of Immunology 146, 1560-1565.
33. Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K. & Desrosiers, R. C. (1992). Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.
34. Davies, A. H. (1995). Advances in the use of recombinant baculoviruses for the expression of heterologous proteins. Current Opinion in Biotechnology 6, 543-547.
35. De, S. K. & Marsh, J. W. (1994). HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. Journal of Biological Chemistry 269, 6656-6660.
36. Deacon, N. J., Tsykin, A., Solomon, A., Smith, K., Ludfordmenting, M., Hooker, D. J., McPhee, D. A., Greenway, A. L., Ellett, A., Chatfield, C., Lawson, V. A., Crowe, S., Maerz, A., Sonza, S., Learmont, J., Sullivan, J. S., Cunningham, A., Dwyer, D., Dowton, D. & Mills, J. (1995). Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
37. Delassus, S., Cheynier, R. & Wain Hobson, S. (1991). Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. Journal of Virology 65, 225-231.
38. de Ronde, A., Klaver, B., Keulen, W., Smit, L. & Goudsmit, J. (1992). Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology 188, 391-395.
39. Dever, T. E. Glynias, M. J. & Merrick, W. C. (1987). GTP-binding domain: three consensus sequence elements with distinct spacing. Proceedings of the National Academy of Sciences, USA 84, 1814-1818.
40. Du, Z., Lang, S. M., Sasseville, V. G., Lackner, A. A., Ilyinskil, P. O., Daniel, M. D., Jung, J. U. & Desrosiers, R. C. (1995). Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82, 665-674.
41. Fiedler, K. & Simons, K. (1995). The role of N-glycans in the secretory pathway. Cell 81, 309-312.
42. Fisher, A. G., Ratner, L., Mitsuya, H., Marselle, L. M., Harper, M. E., Broder, S., Gallo, R. C. & Wong-Staal, F. (1986). Infectious mutants of HTLVX-III with changes in the 3′ region and markedly reduced cytopathic effects. Science 233, 655-659.
43. Foster, J. L., Anderson, S. J., Frazier, A. L. B. & Garcia, J. V. (1994). Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239(open). Virology 201, 373-379.
44. Franchini, G., Robert-Guroff, M., Ghrayeb, J., Chang, N. T. & Wong-Staal, F. (1986). Cytoplasmic localization of the HTLVX-III 3′ orf protein in cultured T cells. Virology 155, 593-599.
45. Freund, J., Kellner, R., Houthaeve, T. & Kalbitzer, H. R. (1994a). Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1. European Journal of Biochemistry 221, 811-819.
46. Freund, J., Kellner, R., Konvalinka, J., Wolber, V., Krausslich, H. G. & Kalbitzer, H. R. (1994b). A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. European Journal of Biochemistry 223, 589-593.
47. Fujii, Y., Nishino, Y., Nakaya, T., Tokunaga, K. & Ikuta, K. (1993). Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells Vaccine 11, 1240-1246.
48. GaedigkNitschko, K., Schon, A., Wachinger, G., Erfle, V. & Kohleisen, B. (1995). Cleavage of recombinant and cell derived human immuno-deficiency virus 1 (HIV-1) Nef protein by HIV-1 protease. FEBS Letters 357, 275-278.
49. Gallimore, A., Cranage, M., Cook, N., Almond, N., Bootman, J., Rud, E., Silvera, P., Dennis, M., Corcoran, T., Stott, J., McMichael, A. & Gotch, F. (1995). Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nature Medicine 1, 1167-1173.
50. Garcia, J. V. & Miller, A. D. (1991). Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511.
51. Garcia, J. V., Alfano, J. & Miller, A. D. (1993). The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4. Journal of Virology 67, 1511-1516.
52. Goldsmith, M. A., Warmerdam, M. T., Atchison, R. E., Miller, M. D. & Greene, W. C. (1995). Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. Journal of Virology 69, 4112-4121.
53. Greenway, A. L., McPhee, D. A., Grgacic, E., Hewish, D., Lucantoni, A., Macreadie, I. & Azad, A. (1994). Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells. Virology 198, 245-256.
54. Greenway, A., Azad, A. & McPhee, D. (1995). Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. Journal of Virology 69, 1842-1850.
55. Grzesiek, S. Bax, A. Clore, G. M. Gronenborn, A. M. Hu, J. Kaufman, J. Palmer, I. Stahl, S. J. & Wingfield, P. T. (1996). The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding site for the SH3 domain of Hck tyrosine protein kinase. Nature Structural Biology 3, 340-345.
56. Guy, B., Kieny, M. P., Riviere, Y., Le Peuch, C., Dott, K., Girard, M., Montagnier, L. & Lecocq, J. (1987). HIV F/3′ orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330, 266-269.
57. Hadida, F., Parrot, A., Kieny, M. P., Sadat Sowti, B., Mayaud, C., Debre, P. & Autran, B. (1992). Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis. Journal of Clinical Investigation 89, 53-60.
58. Hammes, S. R., Dixon, E. P., Malim, M. H., Cullen, B. R. & Greene, W. C. (1989). Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proceedings of the National Academy of Sciences, USA 86, 9549-9553.
59. Harris, M. (1995). The role of myristoylation in the interactions between human immunodeficiency virus type 1 nef and cellular proteins. Biochemical Society Transactions 23, 557-561.
60. Harris, M. & Coates, K. (1993). Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro : a role for myristylation. Journal of General Virology 74, 1581-1589.
61. Harris, M. P. G. & Neil, J. C. (1994). Myristoylation-dependent binding of HIV-1 Nef to CD4. Journal of Molecular Biology 241, 136-142.
62. Harris, M., Hislop, S., Patsilinacos, P. & Neil, J. C. (1992). In vivo derived HIV-1 nef gene products are heterogeneous and lack detectable nucleotide binding activity. AIDS Research and Human Retroviruses 8, 537-543.
63. Hodge, D. R., Chen, Y. M. A. & Samuel, K. P. (1995). Oligomerization of the HIV type 2 Nef protein: mutational analysis of the heptad leucine repeat motif and cysteine residues. AIDS Research and Human Retroviruses 11, 65-79.
64. Huang, Y., Zhang, L. & Ho, D. D. (1995a). Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. Journal of Virology 69, 93-100.
65. Huang, Y., Zhang, L. & Ho, D. D. (1995b). Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection., Journal of Virology 69, 8142-8146.
66. Jamieson, B. D., Aldrovandi, G. M., Planelles, V., Jowett, J. B. M., Gao, L., Bloch, L. M., Chen, I. S. Y. & Zack, J. A. (1994). Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. Journal of Virology 68, 3478-3485.
67. Kaminchik, J., Bashan, N., Pinchasi, D., Amit, B., Sarver, N., Johnston, M. I., Fischer, M., Yavin, Z., Gorecki, M. & Panet, A. (1990). Expression and biochemical characterization of human immunodeficiency virus type I nef gene product. Journal of Virology 64, 3447-3454.
68. Kaminchik, J., Margalit, R., Yaish, S., Drummer, H., Amit, B., Sarver, N., Gorecki, M. & Panet, A. (1994). Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix. AIDS Research and Human Retroviruses 10, 1003-1010.
69. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D. & Desrosiers, R. C. (1991). Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
70. Kienzle, N., Bachmann, M., Muller, W. E. & Mueller-Lantzsch, N. (1992). Expression and cellular localization of the Nef protein from human immunodeficiency virus-1 in stably transfected B-cells. Archives of Virology 124, 123-132.
71. Kienzle, N., Freund, J., Kalbitzer, H. R. & Mueller-Lantzsch, N. (1993). Oligomerization of the nef protein from human immunodeficiency virus (HIV) type 1. European Journal of Biochemistry 214, 451-457.
72. Kim, S., Ikeuchi, K., Byrn, R., Groopman, J. & Baltimore, D. (1989). Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 86, 9544-9548.
73. Kirchoff, F., Greenough, T. C., Brettler, D. B., Sullivan, J. L. & Desrosiers, R. C. (1995). Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. New England Journal of Medicine 332, 228-232.
74. Kohleisen, B., Neumann, M., Herrmann, R., Brack Werner, R., Krohn, K. J., Ovod, V., Ranki, A. & Erfle, V. (1992). Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS 6, 1427-1436.
75. Laurent, A. G., Hovanessian, A. G., Riviere, Y., Krust, B., Regnault, A., Montagnier, L., Findeli, A., Kieny, M. P. & Guy, B. (1990). Production of a non-functional nef protein in human immunodeficiency virus type 1-infected CEM cells. Journal of General Virology 71, 2273-2281.
76. Lee, C. H., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J. & Saksela, K. (1995). A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO Journal 14, 5006-5015.
77. Letourneur, F. & Klausner, R. D. (1992). A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 69, 1143-1157.
78. Luciw, P. A., Cheng-Mayer, C. & Levy, J. A. (1987). Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proceedings of the National Academy of Sciences, USA 84, 1434-1438.
79. Luria, S., Chambers, I. & Berg, P. (1991). Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proceedings of the National Academy of Sciences, USA 88, 5326-5330.
80. Maitra, R. K., Ahmad, N., Holland, S. M. & Venkatesan, S. (1991). Human immunodeficiency virus type I (HIV-1) provirus expression and LTR transcription are repressed in NEF-expressing cell lines. Virology 182, 522-533.
81. Mariani, R. & Skowronski, J. (1993). CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proceedings of the National Academy of Sciences, USA 90, 5549-5553.
82. Matsuura, Y., Maekawa, M., Hattori, S., Ikegami, N., Hayashi, A., Yamazaki, S., Morita, C. & Takebe, Y. (1991). Purification and characterization of human immunodeficiency virus type 1 nef gene product expressed by a recombinant baculovirus. Virology 184, 580-586.
83. Miller, M. D., Warmerdam, M. T., Gaston, I., Greene, W. C. & Feinberg, M. B. (1994). The human immunodeficiency virus-1 nef gene product : a positive factor for viral infection and replication in primary lymphocytes and macrophages. Journal of Experimental Medicine 179, 101-113.
84. Miller, M. D., Warmerdam, M. T., Page, K. A., Feinberg, M. B. & Greene, W. C. (1995). Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. Journal of Virology 69, 579-584.
85. Murphy, K. M., Sweet, M. J., Ross, I. L. & Hume, D. A. (1993). Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages. Journal of Virology 67, 6956-6964.
86. Murti, K. G., Brown, P. S., Ratner, L. & Garcia, J. V. (1993). Highly localized tracks of human immunodeficiency virus type 1 Nef in the nucleus of cells of a human CD4 + T-cell line. Proceedings of the National Academy of Sciences, USA 90, 11895-11899.
87. Nebreda, A. R., Bryan, T., Segade, F., Wingfield, P., Venkatesan, S. & Santos, E. (1991). Biochemical and biological comparison of HIV-1 NEF and ras gene products. Virology 183, 151-159.
88. Niederman, T. M. J., Thielan, B. J. & Ratner, L. (1989). Human immunodeficiency virus type 1 negative factor is a transcriptional silencer. Proceedings of the National Academy of Sciences, USA 86, 1128-1132.
89. Niederman, T. M. J., Hu, W. & Ratner, L. (1991). Simian immunodeficiency virus negative factor suppresses the level of viral mRNA in COS cells. Journal of Virology 65, 3538-3546.
90. Niederman, T. M., Garcia, J. V., Hastings, W. R., Luria, S. & Ratner, L. (1992). Human immunodeficiency virus type 1 Nef protein inhibits NFκB induction in human T cells. Journal of Virology 66, 6213-6219.
91. Niederman, T. M. J., Hastings, W. R., Luria, S., Bandres, J. C. & Ratner, L. (1993). HIV-1 nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells Virology 194, 338-344.
92. Otake, K., Fujii, Y., Nakaya, T., Nishino, Y., Zhong, Q., Fujinaga, K., Kameoka, M., Ohki, K. & Ikuta, K. (1994). The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4 + T cells, Journal of Immunology 153, 5826-5837.
93. Ovod, V., Lagerstedt, A., Ranki, A., Gombert, F. O., Spohn, R., Tahtinen, M., Jung, G. & Krohn, K. J. (1992). Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies. AIDS 6, 25-34.
94. Ranki, A., Jarvinen, K., Valle, S. L., Nurmilaakso, P. & Krohn, K. (1990). Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals. Journal of Acquired Immunodeficiency Syndromes 3, 348-355.
95. Resh, M. D. (1994). Myristylation and palmitylation of Src family members: the fats of the matter. Cell 76, 411-413.
96. Rhee, S. S. & Marsh, J. W. (1994a). HIV-1 Nef activity in murine T cells: CD4 modulation and positive enhancement. Journal of Immunology 152, 5128-5134.
97. Rhee, S. S. & Marsh, J. W. (1994b). Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. Journal of Virology 68, 5156-5163.
98. Robert-Guroff, M., Popovic, M., Gartner, S., Markham, P., Gallo, R. C. & Reitz, M.S. (1990). Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type I in infected lymphocytes and macrophages. Journal of Virology 64, 3391-3398.
99. Rossi, F., Gallina, A. & Milanesi, G. (1996). Nef-CD4 physical interaction sensed with the yeast two-hybrid system. Virology 217, 397-403.
100. Rud, E. W., Yon, J. R., Larder, B. A., Clarke, B. E., Cook, N. & Cranage, M. P. (1992). Infectious molecular clones of SIVmac32H: Nef deletion controls ability to reisolate virus from rhesus macaques. In Vaccines '92: Modern Approaches to New Vaccines including Prevention of AIDS, pp. 229-235. Edited by F. Brown, R. M. Chanock, H. G. Ginsberg & R. A. Lerner. New York: Cold Spring Harbor Laboratory Press.
101. RyanGraham, M. A. & Peden, K. W. C. (1995). Both virus and host components are important for the manifestation of a nef- phenotype in HIV-1 and HIV-2. Virology 213, 158-168.
102. Saksela, K., Cheng, G. & Baltimore, D. (1995). Proline-rich (Pxxp) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef + viruses but not for down-regulation of CD4, EMBO Journal 14, 484-491.
103. Salghetti, S., Marianl, R. & Skowronski, J. (1995). Human immunodeficiency virus type 1 Nef and p56 (Lck) protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proceedings of the National Academy of Sciences, USA 92, 349-353.
104. Samuel, K. P., Seth, A., Konopka, A., Lutenberger, J. A. & Papas, T. S. (1987). The 3′-orf protein of human immunodeficiency virus shows structural homology with the phosphorylation domain of human interleukinX-2 receptor and the ATP-binding site of the protein kinase family. FEBS Letters 218, 81-86.
105. Sanfridson, A., Cullen, B. R. & Doyle, C. (1994). The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. Journal of Biological Chemistry 269, 3917-3920.
106. Sawai, E. T., Baur, A., Struble, H., Peterlin, B. M., Levy, J. A. & Cheng Mayer, C. (1994). Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proceedings of the National Academy of Sciences, USA 91, 1539-1543.
107. Sawai, E. T., Baur, A. S., Peterlin, B. M., Levy, J. A. & Cheng Mayer, C. (1995). A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. Journal of Biological Chemistry 270, 15307-15314.
108. Schwartz, O., Arenzana Seisdedos, F., Heard, J. M. & Danos, O. (1992). Activation pathways and human immunodeficiency virus type 1 replication are not altered in CD4 + T cells expressing the nef protein. AIDS Research and Human Retroviruses 8, 545-551.
109. Schwartz, O., Dautryvarsat, A., Goud, B., Marechal, V., Subtil, A., Heard, J. & Danos, O. (1995). Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. Journal of Virology 69, 528-533.
110. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J. M. (1996). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Medicine 2, 338-342.
111. Shugars, D. C., Smith, M. S., Glueck, D. H., Nantermet, P. V., Seillier-Moiseiwitsch, F. & Swanstrom, R. (1993). Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. Journal of Virology 67, 4639-4650.
112. Spina, C. A., Kwoh, T. J., Chowers, M. Y., Guatelll, J. C. & Rlchman, D. D. (1994). The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. Journal of Experimental Medicine 179, 115-123.
113. Stevenson, M. (1996). Portals of entry: uncovering HIV nuclear transport pathways. Trends in Cell Biology 6, 9-15.
114. Tanaka, T., Ames, J. B., Harvey, T. S., Stryer, L. & Ikura, M. (1995). Sequestration of the membrane-targeting myristoyl group of recoverin in the calcium-free state. Nature 376, 444-447.
115. Terwilliger, E., Sodroski, J. G., Rosen, C. A. & Haseltine, W. A. (1986). Effects of mutations within the 3′ orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity. Journal of Virology 60, 754-760.
116. Unger, R. E., Marthas, M. L., Pratt Lowe, E., Padrid, P. A. & Luciw, P. A. (1992). The nef gene of simian immunodeficiency virus SIVmac1A11. Journal of Virology 66, 5432-5442.
117. Whatmore, A. M., Cook, N., Hall, G. A., Sharpe, S., Rud, E. W. & Cranage, M. P. (1995). Repair and evolution of Nef in vivo modulates simian immunodeficiency virus virulence. Journal of Virology 69, 5117-5123.
118. Yu, G. & Felsted, R. L. (1992). Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. Virology 187, 46-55.
119. Zazopoulos, E. & Haseltine, W. A. (1993). Effect of nef alleles on replication of human immunodeficiency virus type I. Virology 194, 20-27.
120. Zheng, J., Knighton, D. R., Xuong, N. H., Taylor, S. S., Sowadski, J. M. & Eyck, L. F. T. (1993). Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations. Protein Science 2, 1559-1573.
121. Zhou, W., Parent, L. J., Wills, J. W. & Resh, M. D. (1994). Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 gag protein which interacts with acidic phospholipids. Journal of Virology 68, 2556-2569.